Condition: Subarachnoid Hemorrhage, Aneurysmal · Poor Grade Subarachnoid Hemorrhage · Sponsor: IRCCS San Raffaele
Multicentric registry study in order to define outcome, predictors, treatment effects and their modifiers in poor grade aneurysmal subarachnoid haemorrhage patients. The search for outcome predictors is going to be subdivided into three main research areas: 1. outcome predictors in the emergency department (so called "early brain injury phase"). 2. outcome predictors in the neurocritical care unit (so called "delayed brain injury phase"). 3. Treatment strategies. Two other areas of research are identified: delayed cerebral ischemia (incidence, treatment, predictors, impact on outcome) and long term follow-up (recent evidences suggest that there may be a non-negligible proportion of poor grade subarachnoid hemorrhage patients who may benefit from substantial improvement at long-term (after 6-12 months of follow-up).
This description comes directly from the study's public registry record.
Pietro Panni, P.I., M.D. · +393406311389 · panni.pietro@hsr.it
Andrea Falini, Professor of Neuroradiology · +39 0226432239 · falini.andrea@hsr.it
Always discuss trial participation with your own doctor first.
| ASST Ospedale Papa Giovanni XXIII | Bergamo, Italy | Active Not Recruiting |
| IRCCS Bellaria | Bologna, Italy | Recruiting |
| Azienda Ospedaliera Spedali Civili | Brescia, Italy | Recruiting |
| Ospedale Vito Fazzi | Lecce, Italy | Recruiting |
| IRCCS San Raffaele | Milan, Italy | Recruiting |
| Ospedale Maggiore della Città di Novara | Novara, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria di Parma | Parma, Italy | Recruiting |
| Policlinico Universitario Agostino Gemelli | Roma, Italy | Active Not Recruiting |
| Ospedale Santissima Annunziata | Taranto, Italy | Recruiting |
| Azienda Ospedaliera Universitaria Integrata | Verona, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04945603